All 18F-FDG PET/CT scans were performed with a Gemini 16 PET/CT scanner (Philips Medical Systems, Cleveland, OH, USA). The examination technique was performed following previously published guidelines for 18F-FDG imaging in solid malignant tumours issued by the European Association of Nuclear Medicine (EANM) [14 (link)]. All patients fasted for 6 h prior to examination, blood glucose level before the 18F-FDG injection did not exceed 150 mg/dL, and time of 18F-FDG distribution varied from 60 to 75 min. The injected activity was calculated according to previously published guidelines [14 (link)]. The protocol included CT scanning after intravenous injection of iodinated non-ionic contrast agent Ultravist 370 (Bayer AG, Germany), with doses of 1 ml per 1 kg of patient’s weight in portal-venous acquisition phase and oral administration of water for better differentiation of bowel loops.
Gemini 16 pet ct scanner
Manufactured by Philips
Sourced in United States
The Gemini 16 PET/CT scanner is a diagnostic imaging device produced by Philips. It combines positron emission tomography (PET) and computed tomography (CT) technologies to capture comprehensive images of the human body. The scanner simultaneously collects functional and anatomical data, providing healthcare professionals with detailed information for clinical decision-making.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using gemini 16 pet ct scanner
1
PET/CT Imaging Protocol for Solid Tumors
2
PET/CT Evaluation of Pancreatic Cancer Recurrence
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The patients had been administered with 18F-FDG (5 MBq/kg body weight) and imaged for 2.5 minutes per bed after approximately 1-hour 18F-FDG injection on a Gemini 16 PET/CT scanner (Philips Healthcare, Eindhoven, the Netherlands) to identify potential recurrence. 18F-FDG PET/CT images and data of the surgical resection site of remnant pancreas, locoregional lymph nodes, and any distant metastases were reviewed and collected. Areas with a maximum standard uptake value (SUVmax) of 3 or higher were considered with positive PET results.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!